|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017168,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0205249,
umls-concept:C0267055,
umls-concept:C0332173,
umls-concept:C0439231,
umls-concept:C0599724,
umls-concept:C0937846,
umls-concept:C1314677,
umls-concept:C1457887,
umls-concept:C1704419,
umls-concept:C2587213
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-1-24
|
|
pubmed:abstractText |
Esomeprazole, the S-isomer of omeprazole, achieves a significantly greater healing rate and symptom resolution of erosive esophagitis than that achieved by omeprazole. The objective of this study is to assess the efficacy of the new proton pump inhibitor esomeprazole in preventing relapse over a prolonged period in patients with healed erosive esophagitis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
27-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11197282-Administration, Oral,
pubmed-meshheading:11197282-Adult,
pubmed-meshheading:11197282-Aged,
pubmed-meshheading:11197282-Aged, 80 and over,
pubmed-meshheading:11197282-Biopsy, Needle,
pubmed-meshheading:11197282-Confidence Intervals,
pubmed-meshheading:11197282-Dose-Response Relationship, Drug,
pubmed-meshheading:11197282-Double-Blind Method,
pubmed-meshheading:11197282-Drug Administration Schedule,
pubmed-meshheading:11197282-Enzyme Inhibitors,
pubmed-meshheading:11197282-Esophagitis,
pubmed-meshheading:11197282-Female,
pubmed-meshheading:11197282-Follow-Up Studies,
pubmed-meshheading:11197282-Gastric Mucosa,
pubmed-meshheading:11197282-Gastroesophageal Reflux,
pubmed-meshheading:11197282-Humans,
pubmed-meshheading:11197282-Male,
pubmed-meshheading:11197282-Middle Aged,
pubmed-meshheading:11197282-Omeprazole,
pubmed-meshheading:11197282-Probability,
pubmed-meshheading:11197282-Recurrence,
pubmed-meshheading:11197282-Reference Values,
pubmed-meshheading:11197282-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
|
|
pubmed:affiliation |
Eastern Virginia School of Medicine, Norfolk, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
